4703 related articles for article (PubMed ID: 6159628)
1. Control of tumor growth in animals by infusion of an angiogenesis inhibitor.
Langer R; Conn H; Vacanti J; Haudenschild C; Folkman J
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4331-5. PubMed ID: 6159628
[TBL] [Abstract][Full Text] [Related]
2. Vitamin A effect on tumor angiogenesis.
Arensman RM; Stolar CJ
J Pediatr Surg; 1979 Dec; 14(6):809-13. PubMed ID: 95197
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of angiogenesis inhibitor TNP-470 in rabbits bearing VX-2 carcinoma by arterial administration of microspheres and oil solution.
Kamei S; Okada H; Inoue Y; Yoshioka T; Ogawa Y; Toguchi H
J Pharmacol Exp Ther; 1993 Jan; 264(1):469-74. PubMed ID: 7678651
[TBL] [Abstract][Full Text] [Related]
4. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
Prewett M; Huber J; Li Y; Santiago A; O'Connor W; King K; Overholser J; Hooper A; Pytowski B; Witte L; Bohlen P; Hicklin DJ
Cancer Res; 1999 Oct; 59(20):5209-18. PubMed ID: 10537299
[TBL] [Abstract][Full Text] [Related]
5. A factor in conditioned medium of rabbit costal chondrocytes inhibits the proliferation of cultured endothelial cells and angiogenesis induced by B16 melanoma: its relation with cartilage-derived anti-tumor factor (CATF).
Takigawa M; Shirai E; Enomoto M; Pan HO; Suzuki F; Shiio T; Yugari Y
Biochem Int; 1987 Feb; 14(2):357-63. PubMed ID: 2437926
[TBL] [Abstract][Full Text] [Related]
6. Studies on tumor induced angiogenesis.
Ambrus JL; Ambrus CM; Forgach P; Stadler S; Halpern J; Sayyid S; Niswander P; Toumbis C
EXS; 1992; 61():436-44. PubMed ID: 1377568
[TBL] [Abstract][Full Text] [Related]
7. Experimental ocular angiogenesis.
Federman JL; Brown GC; Felberg NT; Felton SM
Am J Ophthalmol; 1980 Feb; 89(2):231-7. PubMed ID: 6153510
[TBL] [Abstract][Full Text] [Related]
8. Vitreous inhibition of tumor neovascularization.
Felton SM; Brown GC; Felberg NT; Federman JL
Arch Ophthalmol; 1979 Sep; 97(9):1710-3. PubMed ID: 475643
[TBL] [Abstract][Full Text] [Related]
9. Protamine is an inhibitor of angiogenesis.
Taylor S; Folkman J
Nature; 1982 May; 297(5864):307-12. PubMed ID: 6176876
[No Abstract] [Full Text] [Related]
10. Isolations of a cartilage factor that inhibits tumor neovascularization.
Langer R; Brem H; Falterman K; Klein M; Folkman J
Science; 1976 Jul; 193(4247):70-2. PubMed ID: 935859
[TBL] [Abstract][Full Text] [Related]
11. TNP-470 fails to block the onset of angiogenesis and early tumor establishment in an intravital minimal disease model.
Cernaianu G; Frank S; Erbstösser K; Leonhardt S; Cross M; McIvor Z; Scholz G; Dansranjavin T; Celik I; Tannapfel A; Wittekind C; Troebs RB; Rothe K; Bennek J; Hauss J; Witzigmann H
Int J Colorectal Dis; 2006 Mar; 21(2):143-54. PubMed ID: 15937694
[TBL] [Abstract][Full Text] [Related]
12. Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis.
Struyf S; Burdick MD; Peeters E; Van den Broeck K; Dillen C; Proost P; Van Damme J; Strieter RM
Cancer Res; 2007 Jun; 67(12):5940-8. PubMed ID: 17575164
[TBL] [Abstract][Full Text] [Related]
13. [Experiments concerning tumor angiogenesis ].
Rochels R
Graefes Arch Clin Exp Ophthalmol; 1982; 219(1):20-3. PubMed ID: 6180959
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor increases tumor growth and angiogenesis directly by promoting endothelial cell function and indirectly by enhancing the mobilization and recruitment of proangiogenic granulocytes.
Zheng Q; Li X; Cheng X; Cui T; Zhuo Y; Ma W; Zhao X; Zhao P; Liu X; Feng W
Tumour Biol; 2017 Feb; 39(2):1010428317692232. PubMed ID: 28240048
[TBL] [Abstract][Full Text] [Related]
15. Gold(III) porphyrin 1a prolongs the survival of melanoma-bearing mice and inhibits angiogenesis.
Lum CT; Huo L; Sun RW; Li M; Kung HF; Che CM; Lin MC
Acta Oncol; 2011 Jun; 50(5):719-26. PubMed ID: 21110776
[TBL] [Abstract][Full Text] [Related]
16. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
Sheu JR; Fu CC; Tsai ML; Chung WJ
Anticancer Res; 1998; 18(6A):4435-41. PubMed ID: 9891506
[TBL] [Abstract][Full Text] [Related]
17. PPARalpha deficiency in inflammatory cells suppresses tumor growth.
Kaipainen A; Kieran MW; Huang S; Butterfield C; Bielenberg D; Mostoslavsky G; Mulligan R; Folkman J; Panigrahy D
PLoS One; 2007 Feb; 2(2):e260. PubMed ID: 17327920
[TBL] [Abstract][Full Text] [Related]
18. LY317615 decreases plasma VEGF levels in human tumor xenograft-bearing mice.
Keyes KA; Mann L; Sherman M; Galbreath E; Schirtzinger L; Ballard D; Chen YF; Iversen P; Teicher BA
Cancer Chemother Pharmacol; 2004 Feb; 53(2):133-40. PubMed ID: 14593497
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
[TBL] [Abstract][Full Text] [Related]
20. A novel angiogenic inhibitor derived from Japanese shark cartilage (I). Extraction and estimation of inhibitory activities toward tumor and embryonic angiogenesis.
Oikawa T; Ashino-Fuse H; Shimamura M; Koide U; Iwaguchi T
Cancer Lett; 1990 Jun; 51(3):181-6. PubMed ID: 1693543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
